These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Diagnosis and management of Clostridioides difficile infection in patients with inflammatory bowel disease. Dalal RS; Allegretti JR Curr Opin Gastroenterol; 2021 Jul; 37(4):336-343. PubMed ID: 33654015 [TBL] [Abstract][Full Text] [Related]
7. Antibiotics for Treatment of Clostridium difficile Infection in Hospitalized Patients with Inflammatory Bowel Disease. Horton HA; Dezfoli S; Berel D; Hirsch J; Ippoliti A; McGovern D; Kaur M; Shih D; Dubinsky M; Targan SR; Fleshner P; Vasiliauskas EA; Grein J; Murthy R; Melmed GY Antimicrob Agents Chemother; 2014 Sep; 58(9):5054-9. PubMed ID: 24913174 [TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes and treatment necessity in patients with toxin-negative Clostridioides difficile stool samples. Cho DH; Kim SH; Jeon CH; Kim HT; Park KJ; Kim J; Kwak J; Kwan BS; Kong S; Lee JW; Kim KM; Wi YM Ann Clin Microbiol Antimicrob; 2024 Apr; 23(1):35. PubMed ID: 38664689 [TBL] [Abstract][Full Text] [Related]
9. Case-Control Study of Inflammatory Bowel Disease Patients with and without Clostridium difficile Infection and Poor Outcomes in Patients Coinfected with C. difficile and Cytomegalovirus. Li Y; Xu H; Xu T; Xiao M; Tang H; Wu D; Tan B; Li J; Yang H; Lv H; Xu Y; Qian J Dig Dis Sci; 2018 Nov; 63(11):3074-3083. PubMed ID: 30094621 [TBL] [Abstract][Full Text] [Related]
10. Predictors of Clostridioides difficile Infection-Related Complications and Treatment Patterns among Nucleic Acid Amplification Test-Positive/Toxin Enzyme Immunoassay-Negative Patients. Miller R; Morillas JA; Brizendine KD; Fraser TG J Clin Microbiol; 2020 Feb; 58(3):. PubMed ID: 31896665 [TBL] [Abstract][Full Text] [Related]
11. Anti-TNF containing regimens may be associated with increased risk of Clostridioides difficile infection in patients with underlying inflammatory bowel disease. Gholam-Mostafaei FS; Yadegar A; Aghdaei HA; Azimirad M; Daryani NE; Zali MR Curr Res Transl Med; 2020 Aug; 68(3):125-130. PubMed ID: 32414632 [TBL] [Abstract][Full Text] [Related]
12. Clostridium difficile infection in patients with inflammatory bowel disease: a case control study. Vitikainen K; Haapamäki J; Färkkilä M; Anttila VJ; Arkkila P Scand J Gastroenterol; 2018 Aug; 53(8):947-951. PubMed ID: 30041549 [TBL] [Abstract][Full Text] [Related]
14. Long-Duration Oral Vancomycin to Treat Clostridioides difficile in Patients With Inflammatory Bowel Disease Is Associated With a Low Rate of Recurrence. Lei DK; Ollech JE; Andersen M; Weisshof R; Zmeter N; Sossenheimer P; Rubin DT Am J Gastroenterol; 2019 Dec; 114(12):1904-1908. PubMed ID: 31714359 [TBL] [Abstract][Full Text] [Related]
15. Dual Reporting of Clostridioides difficile PCR and Predicted Toxin Result Based on PCR Cycle Threshold Reduces Treatment of Toxin-Negative Patients without Increases in Adverse Outcomes. Hitchcock MM; Holubar M; Hogan CA; Tompkins LS; Banaei N J Clin Microbiol; 2019 Nov; 57(11):. PubMed ID: 31511334 [TBL] [Abstract][Full Text] [Related]
16. Clostridioides difficile Infection in Children With Inflammatory Bowel Disease. Chandrakumar A; Zohni H; El-Matary W Inflamm Bowel Dis; 2020 Oct; 26(11):1700-1706. PubMed ID: 31765471 [TBL] [Abstract][Full Text] [Related]
17. Clinical Significance of Toxigenic Clostridioides difficile Growth in Stool Cultures during the Era of Nonculture Methods for the Diagnosis of C. difficile Infection. Lee CC; Lee JC; Chiu CW; Tsai PJ; Ko WC; Hung YP Microbiol Spectr; 2021 Oct; 9(2):e0079921. PubMed ID: 34668727 [TBL] [Abstract][Full Text] [Related]
18. Molecular characterization and antibiotic resistance of Clostridioides difficile in patients with inflammatory bowel disease from two hospitals in China. Lv T; Zheng L; Wu T; Shen P; Chen Y J Glob Antimicrob Resist; 2022 Sep; 30():252-258. PubMed ID: 35764214 [TBL] [Abstract][Full Text] [Related]